The Development Of Drugs That Target FGFR Signaling Is Driving The Growth Of Achondroplasia Treatment Market
by Market Overview: Achondroplasia is the most common type of dwarfism. It is caused by a genetic mutation that prevents skeletal growth at the ends of …